Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class I · High risk Terminated Initiated Sep 6, 2019 (7 years ago)

Quinacrine Dihydrochloride

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Label Mix-Up: Product labeled as Quinacrine Dihydrochloride; however, after testing, identified as Artemisinin.

Cause type: Labeling / mix-up

Wrong label, wrong strength, mixed-up products, or packaging errors. One of the most dangerous causes - you can end up taking the wrong drug or the wrong dose. All labeling / mix-up recalls.

What was recalled

Quinacrine Dihydrochloride (98.25%), bulk API product, packaged in a) 500 g NDC# 71052-530-05; b) 50 g NDC# 71052-530-55, c) 25g NDC# 71052-530-25, Darmerica LLC 198 Wilshire Blvd Casselberry, FL 32707

Affected NDCs 71052-0530-05 71052-0530-25 71052-0530-55

Compare with the code on your package — it is the most precise check available.

Recalling firm
Darmerica, LLC
NDC code
71052-530-05
Origin
FL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0125-2020 · FDA notice

Treat this as urgent. Class I means FDA judged there is a reasonable probability of serious harm. Find the lot number on your package; if it matches the recalled lots, do not take another dose before you have spoken to your pharmacist or prescriber - today, not next week. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other labeling / mix-up recalls from 2019

All labeling / mix-up recalls
Class II · Moderate risk

Theraflu Cough Relief

Labeling: Label Lacks Warning: Product recalled due to absence of a warning statement on the product label, Ask a doctor before use if you have a sodium-restricted diet.

Terminated Labeling / mix-up GSK Consumer Health, Inc D-0996-2020
Class II · Moderate risk

Testosterone Topical Cream 4%

Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.

Terminated Labeling / mix-up MPRX, Inc. dba Medical Park Pharmacy D-0820-2020
Class II · Moderate risk

Tadalafil 6 mg Capsule

Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.

Terminated Labeling / mix-up MPRX, Inc. dba Medical Park Pharmacy D-0819-2020
Class II · Moderate risk

Tadalafil 20 mg Troche

Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.

Terminated Labeling / mix-up MPRX, Inc. dba Medical Park Pharmacy D-0818-2020